Loading...
Mogamulizumab-kpkc: A Novel Therapy for the Treatment of Cutaneous T-Cell Lymphoma
Mogamulizumab-kpkc provides a novel mechanism of action for the treatment of mycosis fungoides and Sézary syndrome. The efficacy and safety of mogamulizumab-kpkc for the treatment of relapsed or refractory mycosis fungoides and Sézary syndrome were demonstrated in a multicenter, open-label, randomiz...
Na minha lista:
| Udgivet i: | J Adv Pract Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Harborside Press LLC
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7517756/ https://ncbi.nlm.nih.gov/pubmed/33425472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2019.10.8.10 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|